Drug Combination Details
General Information of the Combination (ID: C77184) | |||||
---|---|---|---|---|---|
Name | Gambogic acid NP Info | + | Imatinib Drug Info | ||
Structure | + | ||||
Disease |
Acute lymphoblastic leukemia
[ICD-11: 2B33]
|
Investigative | [1] |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. Reversing Drug Resistance by This Combination | ||||||
Reversing Drug Resistance | Click to Show/Hide | |||||
Experiment 1 Reporting the Effect of This Combination | [1] | |||||
Molecule(s)
Regulation |
Down-regulation | Phosphorylation | ABL | Molecule Info |
Pathway MAP
|
|
Up-regulation | Expression | AIFM1 | Molecule Info |
Pathway MAP
|
||
Down-regulation | Phosphorylation | AKT1 | Molecule Info |
Pathway MAP
|
||
Down-regulation | Expression | BCL-2 | Molecule Info |
Pathway MAP
|
||
Down-regulation | Phosphorylation | BCR | Molecule Info |
Pathway MAP
|
||
Up-regulation | Cleavage | CASP3 | Molecule Info |
Pathway MAP
|
||
Up-regulation | Cleavage | CASP8 | Molecule Info |
Pathway MAP
|
||
Up-regulation | Cleavage | CASP9 | Molecule Info |
Pathway MAP
|
||
Down-regulation | Phosphorylation | CRKL | Molecule Info |
Pathway MAP
|
||
Down-regulation | Phosphorylation | ERK1 | Molecule Info |
Pathway MAP
|
||
Down-regulation | Phosphorylation | ERK2 | Molecule Info |
Pathway MAP
|
||
Down-regulation | Expression | MCL1 | Molecule Info |
Pathway MAP
|
||
Down-regulation | Phosphorylation | STAT5B | Molecule Info |
Pathway MAP
|
||
Down-regulation | Expression | XIAP | Molecule Info |
Pathway MAP
|
||
Biological
Regulation |
Up-regulation | Cytochrome c release | ||||
In-vitro Model | KBM-5 | CVCL_0373 | Chronic myelogenous leukemia | Homo sapiens | ||
K-562 | CVCL_0004 | Chronic myelogenous leukemia | Homo sapiens | |||
KBM5-T315I | Chronic myeloid leukemia | Homo sapiens | ||||
In-vivo Model | A total of 3 * 107 of KBM5 or KBM5-T315I cells were inoculated subcutaneously on the flanks of 5-week-old male nude mice. | |||||
Experimental
Result(s) |
Gambogic acid induces apoptosis in imatinib-resistant chronic myeloid leukemia cells via inducing proteasome inhibition and caspase-dependent Bcr-Abl downregulation. |